Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults - A Randomised Controlled Trial
Latest Information Update: 19 Oct 2023
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms Bone Zone
- 14 Mar 2023 Gender amended. Previously the trials was in females only now both male and female participants are involved.
- 14 Jul 2021 Status changed from not yet recruiting to recruiting.
- 02 Nov 2020 New trial record